The data revealed that compound 1 have much higher cytotoxicity than 18 in four breast cancer cell lines and KDM5A inhibitors selectively inhibit breast cancer cell lines (Figure 4A–E and Figure S5). This evidence concerns the gene KDM5A and breast carcinoma.